Successful treatment with cyclosporine and anti-tumour necrosis factor agent for deficiency of adenosine deaminase-2.
Scand J Rheumatol
; 50(3): 243-245, 2021 May.
Article
in En
| MEDLINE
| ID: mdl-32720851
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenosine Deaminase
/
Severe Combined Immunodeficiency
/
Cyclosporine
/
Agammaglobulinemia
/
Etanercept
/
Tumor Necrosis Factor Inhibitors
/
Immunosuppressive Agents
Limits:
Adolescent
/
Female
/
Humans
Language:
En
Journal:
Scand J Rheumatol
Year:
2021
Type:
Article
Affiliation country:
Japan